Literature DB >> 24481594

Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4.

Yongliang Gu1, Wei Wang, Xiaolei Zhu, Keke Dong.   

Abstract

We apply molecular docking, molecular dynamics (MD) simulation, and binding free energy calculation to investigate and reveal the binding mechanism between five xanthine inhibitors and DPP-4. The electrostatic and van der Waals interactions of the five inhibitors with DPP-4 are analyzed and discussed. The computed binding free energies using MM-PBSA method are in qualitatively agreement with experimental inhibitory potency of five inhibitors. The hydrogen bonds of inhibitors with Ser630 and Asp663 can stabilize the inhibitors in binding sites. The van der Waals interactions, especially the key contacts with His740, Asn710, Trp629, and Tyr666 have larger contributions to the binding free energy and play important roles in distinguishing the variant bioactivity of five inhibitors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481594     DOI: 10.1007/s00894-014-2075-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  58 in total

Review 1.  The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

Authors:  P King; I Peacock; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.

Authors:  S Tanaka; T Murakami; H Horikawa; M Sugiura; K Kawashima; T Sugita
Journal:  Int J Immunopharmacol       Date:  1997-01

3.  cis-2,5-dicyanopyrrolidine inhibitors of dipeptidyl peptidase IV: synthesis and in vitro, in vivo, and X-ray crystallographic characterization.

Authors:  Stephen W Wright; Mark J Ammirati; Kim M Andrews; Anne M Brodeur; Dennis E Danley; Shawn D Doran; Jay S Lillquist; Lester D McClure; R Kirk McPherson; Stephen J Orena; Janice C Parker; Jana Polivkova; Xiayang Qiu; Walter C Soeller; Carolyn B Soglia; Judith L Treadway; Maria A VanVolkenburg; Hong Wang; Donald C Wilder; Thanh V Olson
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 4.  Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors:  A R Saltiel; J M Olefsky
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

5.  Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

Authors:  M A Nauck; U Niedereichholz; R Ettler; J J Holst; C Orskov; R Ritzel; W H Schmiegel
Journal:  Am J Physiol       Date:  1997-11

6.  Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Authors:  J Rosenstock; S L Schwartz; C M Clark; G D Park; D W Donley; M B Edwards
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

7.  Molecular dynamics simulations and MM/GBSA methods to investigate binding mechanisms of aminomethylpyrimidine inhibitors with DPP-IV.

Authors:  Liang Desheng; Gao Jian; Cheng Yuanhua; Cui Wei; Zhang Huai; Ji Mingjuan
Journal:  Bioorg Med Chem Lett       Date:  2011-09-29       Impact factor: 2.823

Review 8.  Current therapies and emerging targets for the treatment of diabetes.

Authors:  A S Wagman; J M Nuss
Journal:  Curr Pharm Des       Date:  2001-04       Impact factor: 3.116

Review 9.  DPP4 inhibitors for diabetes--what next?

Authors:  Anne-Marie Lambeir; Simon Scharpé; Ingrid De Meester
Journal:  Biochem Pharmacol       Date:  2008-07-31       Impact factor: 5.858

10.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Authors:  T J Kieffer; C H McIntosh; R A Pederson
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

View more
  3 in total

1.  Latest QSAR study of adenosine Α₂Β receptor affinity of xanthines and deazaxanthines.

Authors:  Alfonso Pérez-Garrido; Virginia Rivero-Buceta; Gaspar Cano; Sanjay Kumar; Horacio Pérez-Sánchez; Marta Teijeira Bautista
Journal:  Mol Divers       Date:  2015-07-10       Impact factor: 2.943

2.  Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor.

Authors:  Hiroyuki Nojima; Kazuhiko Kanou; Genki Terashi; Mayuko Takeda-Shitaka; Gaku Inoue; Koichiro Atsuda; Chihiro Itoh; Chie Iguchi; Hajime Matsubara
Journal:  BMC Struct Biol       Date:  2016-08-05

Review 3.  Recent Developments and Applications of the MMPBSA Method.

Authors:  Changhao Wang; D'Artagnan Greene; Li Xiao; Ruxi Qi; Ray Luo
Journal:  Front Mol Biosci       Date:  2018-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.